← Back to search

Ultragenyx Pharmaceutical Inc

RARE · NASDAQ

Pharmaceutical Preparation Manufacturing

Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.

ESG Scores

Overall ESG
6.1
Environmental
4.6
Social
3.7
Governance
6.8

Gender Diversity

Female Directors0.3333%
Female Executives0.38095238095238093%
Women in Workforce0.57%
CEO GenderMale